Oxolinic acid
An article about the antibiotic oxolinic acid
| Oxolinic acid | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Oxolinic acid is a quinolone antibiotic that is used primarily in veterinary medicine. It is a synthetic chemotherapeutic agent that belongs to the class of naphthyridones, which are structurally related to the quinolones. Oxolinic acid is known for its ability to inhibit bacterial DNA gyrase, an enzyme critical for DNA replication in bacteria.
Mechanism of Action[edit]
Oxolinic acid functions by targeting the bacterial DNA gyrase, an enzyme that introduces negative supercoils into DNA. This process is essential for DNA replication and transcription. By inhibiting DNA gyrase, oxolinic acid prevents the replication of bacterial DNA, thereby exerting its bactericidal effects.
Uses[edit]
Oxolinic acid is primarily used in veterinary medicine to treat infections caused by Gram-negative bacteria. It is effective against a variety of bacterial species, including those that cause urinary tract infections and gastrointestinal infections in animals.
Pharmacokinetics[edit]
After administration, oxolinic acid is absorbed and distributed throughout the body. It is metabolized in the liver and excreted primarily through the kidneys. The pharmacokinetic properties of oxolinic acid can vary depending on the species being treated.
Side Effects[edit]
Like other antibiotics, oxolinic acid can cause side effects. Common side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. In some cases, allergic reactions may occur.
Resistance[edit]
Bacterial resistance to oxolinic acid can develop through mutations in the genes encoding DNA gyrase. This resistance can limit the effectiveness of the drug and is a concern in both human and veterinary medicine.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian